Home
Join A Case
Contact
MoreAccording to the Complaint, the Company made false and misleading statements to the market. Despite its comments to the contrary, bluebird would fail to secure FDA approval for lovo-cel without a black box warning. The Company overstated the commercial prospects of lovo-cel. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about bluebird, investors suffered damages.
Archives: Cases
Sotera Health Company
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company (“Sotera” or “the Company”) (NASDAQ: SHC) for violations of the securities laws.
Plug Power Inc.
According to the Complaint, the Company made false and misleading statements to the market. Plug overstated its ability to mitigate problems related to supply chain slowdowns and material shortages. The Company’s hydrogen production building plans continued to experience delays. The Company downplayed the extent of these issues. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Plug, investors suffered damages.
Evolv Technologies Holdings, Inc.
According to the Complaint, the Company made false and misleading statements to the market. Evolv overstated the efficacy of its products. The Company’s products and their inability to effectively detect guns and knives led to an increase of undetected weapons entering sensitive locations such as schools. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Evolv, investors suffered damages.
Sterling Check Corp.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Sterling Check Corp. (“Sterling Check” or “the Company”) (NASDAQ: STER) for potential breaches of fiduciary duty on the part of its directors and management.
MeridianLink, Inc.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in MeridianLink, Inc. (“MeridianLink” or “the Company”) (NYSE: MLNK) for potential breaches of fiduciary duty on the part of its directors and management.
Shoals Technologies Group, Inc.
According to the Complaint, the Company made false and misleading statements to the market. Shoals failed to deliver electrical balance of system (“EBOS”) products at a high level of reliability and quality. The Company was aware that a large number of its EBOS systems used in solar fields were defective. The Company incurred costs of between $60 million and $185 million to remediate its defective products. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Shoals, investors suffered damages.
The Chemours Company
According to the Complaint, the Company made false and misleading statements to the market. Chemours’ management team manipulated targets for free cash flow to maximize executive compensation under its Annual Incentive Plans and Long-Term Incentive Plans. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Chemours, investors suffered damages.
Equinix, Inc.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Equinix is the subject of a report released by Hindenburg Research on March 20, 2024, titled: “Equinix Exposed: Major Accounting Manipulation, Core Business Decay And Selling an AI Pipe Dream As Insiders Cashed Out Hundreds of Millions.” According to the report Hindenburg’s “investigation, which included a review of financial and litigation records and interviews with 37 former Equinix employees, industry experts and competitors, revealed that Equinix manipulates its accounting for AFFO (“adjusted funds from operations”), the key profitability metric for REITs. We estimate this metric was overstated by at least 22% in 2023 alone.”
Inari Medical, Inc.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Inari filed an Annual Report on Form 10-K on February 28, 2024, stating, “on December 2023, we received a civil investigative demand (“CID”) from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the “Investigation”). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”). We are cooperating with the Investigation. We are unable to express a view at this time regarding the likely duration, or ultimate outcome, of the Investigation or estimate the possibility of, or amount or range of, any possible financial impact. Depending on the outcome of the Investigation, there may be a material impact on our business, results of operations, or financial condition.”